Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2025-12-03 | Mr. David G. ElsleyPresident, CEO & Director | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 675,00k | 107,69% |
| 2025-12-03 | Mr. Christopher J. WaddickCFO, Corporate Secretary & Director | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 250,00k | - |
| 2025-12-03 | Mr. Colin G. StottIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Ms. Jennifer M. ChaoIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Mr. Peter PekosIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 250,00k | - |
| 2025-12-03 | Ms. Teri LoxamIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 120,00k | 100,00% |
| 2025-12-03 | Dr. Guillermo Torre-AmioneIndependent Chairman | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Mr. Bernard LimCOO | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 250,00k | - |
| 2025-12-03 | Dr. Timothy J. GarnettIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 120,00k | 100,00% |
| 2025-10-01 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 133,33k | 0,00 | Derivative Exercise and Retained Stock | - | 669,95k | 24,85% |
| 2025-10-17 | Mr. David G. ElsleyPresident, CEO & Director | 100,00k | 100,00k | Achat | 1,00 | 1,34M | 8,04% |
| 2025-10-17 | Dr. Guillermo Torre-AmioneIndependent Chairman | 50,00k | 50,00k | Achat | 1,00 | 309,31k | 19,28% |
| 2025-09-08 | Ms. Teri LoxamIndependent Director | 13,33k | 0,00 | Derivative Exercise and Retained Stock | - | 133,33k | 11,11% |
| 2025-09-08 | Ms. Jennifer M. ChaoIndependent Director | 13,33k | 0,00 | Derivative Exercise and Retained Stock | - | 133,33k | 11,11% |
| 2025-09-08 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 70,00k | 0,00 | Derivative Exercise and Retained Stock | - | 536,61k | 15,00% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
